In that scenario, why would drug companies bother to develop drugs that deeply impart public health? They already prioritize drugs for smaller numbers of rich people rather than drugs for larger numbers of poor people (e.g. antibiotics). If they can't make a large profit off of developing an AIDS vaccine, they're going to work on something like weight-loss drugs instead.

[–] JoMiran@lemmy.ml 4 points 3 months ago

Carrot and stick. The carrot is money for R&D plus a guaranteed purchase of their stock at a fixed and profitable markup. The stick is a regulatory hellscape and guaranteed perpetual purgatory for their other meds if they don't play ball. Keep the gov happy, and the gov keeps you fat and rich. Drag your feet on critical care meds and risk your skinny pills not be sold in the main market for them.

[–] baru@lemmy.world 2 points 3 months ago

A lot of that research isn't done by these companies. Further, their marketing budget is often huge, the research budget is often lower than that.